RDH10 Antikörper (AA 201-300) (Cy7)
Kurzübersicht für RDH10 Antikörper (AA 201-300) (Cy7) (ABIN1412112)
Target
Alle RDH10 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 201-300
-
Homologie
- Human,Mouse,Rat,Sheep,Pig,Horse,Chicken
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human RDH10
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- RDH10 (Retinol Dehydrogenase 10 (All-Trans) (RDH10))
-
Andere Bezeichnung
- RDH10
-
Hintergrund
-
Synonyms: RDH 10, RDH10, RDH10_HUMAN, Retinol dehydrogenase 10 all trans, Retinol dehydrogenase 10, SDR16C4, Short chain dehydrogenase/reductase family 16C member 4.
Background: Retinol dehydrogenase with a clear preference for NADP. Converts all-trans-retinol to all-trans-retinal. Has no detectable activity towards 11-cis-retinol, 9-cis-retinol and 13-cis-retinol.
Target
-